The global Diabetes Pen Market was valued at USD 5.86 billion in 2016 and is projected to reach USD 11.19 billion by 2025, growing at a CAGR of 7.45% from 2017 to 2025.
An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. The increasing prevalence of diabetic patients all over the globe paired with increasing geriatric population are some drivers to the market.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Growth in prevalence of diabetes cases in varied age group
1.2 Growth in product launches
1.3 Promising regulations
1.4 Growth in awareness amongst people
2. Market Restraints
2.1 Increased R&D investments.
2.2 Safety issues related to reusable injection pen restrain the market
Market Segmentation:
1. Global Diabetes Pen Market, by Indication:
1.1 type I diabetes
1.2 type II diabetes
2. Global Diabetes Pen Market, by ProductType:
2.1 Insulin Pens
2.2 Insulin pen needles
3. Global Diabetes Pen Market, by Types:
3.1 Disposable
3.2 Reusable
4. Global Diabetes Pen Market, by Therapies:
4.1 insulin
4.2 glucagon-like peptide-1
4.3 growth hormones
5. Global Diabetes Pen Market, by End User:
5.1 hospitals
5.2 clinics
5.3 home care settings
6. Global Diabetes Pen Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Astra Zeneca
2. BD
3. Eli Lilly and Company
4. Biocon
5. Sanofi
6. Jiangsu Delfu medical device Co.,Ltd.
7. Owen Mumford Ltd.
8. WOCKHARDT
9. Smiths Group plc.
10. P&B Pharmaceuticals Ltd.
11. NIPRO Medical Corporation
12. Novo Nordisk A/S
13. Injex UK
14. Mannkind Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Diabetes Pen Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL DIABETES PEN MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL DIABETES PEN MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL DIABETES PEN MARKET, BY INDICATION
5.1 Type I diabetes
5.2 Type II diabetes
6 GLOBAL DIABETES PEN MARKET, BY PRODUCT TYPE
6.1 Insulin Pens
6.2 Insulin pen needles
7 GLOBAL DIABETES PEN MARKET, BY TYPE
7.1 Disposable
7.2 Reusable
8 GLOBAL DIABETES PEN MARKET, BY THERAPIE
8.1 Insulin
8.2 Glucagon-like peptide-1
8.3 Growth hormones
9 GLOBAL DIABETES PEN MARKET, BY END USER
9.1 Hospitals
9.2 Clinics
9.3 Home care settings
10 GLOBAL DIABETES PEN MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
11 GLOBAL DIABETES PEN MARKET COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Astra Zeneca
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 BD
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Eli Lilly and Company
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Biocon
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Sanofi
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Jiangsu Delfu medical device Co.,Ltd.
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 Owen Mumford Ltd.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 WOCKHARDT
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Smiths Group plc.
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 P&B Pharmaceuticals Ltd.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
12.11 NIPRO Medical Corporation
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments
12.12 Novo Nordisk A/S
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments
12.13 Injex UK
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments
12.14 Mannkind Corporation
12.14.1 Overview
12.14.2 Financial Performance
12.14.3 Product Outlook
12.14.4 Key Developments
13 Appendix
13.1 Related Reports
The Pediatric Diabetes Therapeutic Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
Executive Summary
Azoth Analytics has released a research report titled "Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market (2024 Edition)" which provides a complete analysis of the Global Glucagon-Like Peptide 1 (GLP-1) Agonist industry in terms of market segmentation By Type (Tirze...
Overview of the Global Mobile Diabetes Technology Solutions Market:
The report discusses everything a marketer requires before investing in the global Mobile Diabetes Technology Solutions Market during the forecast ...
Executive Summary
Azoth Analytics has released a research report titled "Cell Therapies For Type I Diabetes (2023 Edition)" which provides a complete analysis of the pipeline of Cell Therapies For Type I Diabetes, Target Market Opportunity by country and epidemiology of the Disease....
The global Inadequately Controlled Type-II Diabetes Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which wi...
The global Diabetes Drugs market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field...
The global Non Insulin Anti diabetes Drugs market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market play...
The global Diabetes Treatment Drugs market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Diabetes Treatment Device market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in...
The global Home Diabetes Care Device market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in...